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Analysis of effectiveness
The analysis of effectiveness was based on intention to treat. The main health outcome used in the analysis was procedure patency assessed in all patients 2 months after the procedure and at intervals during the following years. Analysis of patency in each group was performed using Kaplan Meyer analysis. The success rate of the procedure, in terms of successful stenting or bypass, as well as complication rates was also considered. Groups were shown to be comparable at analysis in terms of mean age (67.9 years for crossover group/61.9 years for stent), with 10.5 standard deviation (SD) for the crossover graft group and 10.1 SD for the stent group.
Effectiveness results
Intention to treat patency following stent insertion at 6 months was 52%, compared to 100% patency after crossover grafting, (p<0.0001).
Stented arteries suffered a rapid fall in patency over the first 6 months to 78% (secondary) declining to 68% at 4 years.
In 13 cases, it was impossible to place the stent successfully.
In a further 10 stented patients, major complications occurred which were mainly thromboembolic.
15 patients underwent crossover grafting after failure to insert a stent or after stent occlusion.
No major complications occurred following crossover grafting.
Clinical conclusions
With only one graft occlusion at 24 months, crossover grafting appears to be a durable procedure.
Modelling
Analysis of patency in each group was performed using Kaplan Meyer analysis.
Measure of benefits used in the economic analysis
The authors did not provide a summary measure of benefits, and, as such, a cost-consequences analysis was conducted.
Direct costs
Direct hospital costs were considered in the analysis, namely: device costs, including insertion devices, packs, sterile drapes, drugs and contrast; theatre and angiogram suite cost, hourly rate including all staff costs and anaesthetic/recovery time; and cost of overnight stay.
Although not explicitly stated, it appears that costs related to the authors' institution. For some cost components, quantities and costs were presented separately; such as mean duration of the procedure and theatre and angiogram suite costs, length of stay and overnight stay costs. Whilst the main determinant of cost, length of stay, was reported as
